Biotech group Chi-Med files for HK listing, may raise up to $500m

Photo: Pixabay

Biotech company Hutchison China MediTech, known as ChiMed, has filed for a Hong Kong listing, which four sources close to the matter said could raise up to $500 million.

Continue reading this story with a subscription to DealStreetAsia.


Contact us for corporate subscriptions at